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Summary A cell-free plasmid reactivation assay was used to determine the fidelity of DNA double-strand break (DSB) repair in a panel of
eight DSB repair-proficient human tumour cell lines. Nuclear protein extracts derived from radiosensitive tumour cells were less capable of
correctly rejoining EcoRI-induced DSBs than were similar extracts from radioresistant tumour cells. Linear regression analysis suggests that
there was a significant (r2 = 0.84, P = 0.001, d.f. = 6) correlation between the fidelity of DSB rejoining and the SF2 values of the cell lines
studied. This cell-free assay is clearly sensitive to differences in the nuclear protein composition that reflect the clinically relevant
radiosensitivity of these cell lines. The fact that our cell-free assay yielded similar results to previous studies that used intracellular plasmid
reactivation assays suggests that those differences in DSB mis-rejoining frequencies in radiosensitive and radioresistant cell lines may be
due to inherent differences in nuclear protein composition and are not directly attributable to differences in proliferation rates between cell
lines. The underlying cause for this association between DSB mis-rejoining frequencies and radiosensitivity is presently unknown, however
restriction endonuclease mapping and polymerase chain reaction (PCR) amplification analysis revealed that approximately 40% of the mis-
rejoined DSBs arose as a result of the deletion of between 40 and 440 base pairs. These data raise the possibility that the radiosensitivity of
DSB repair-proficient human tumour cell lines may be partly determined by the predisposition of these cell lines to activate non-conservative
DSB rejoining pathways.
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The concept that clinical radioresponsiveness is a function of the
intrinsic radiosensitivity oftumourcells (Fertil and Malaise, 1980;
Deacon et al, 1984) has led to considerable interest in identifying
the basis for the variation in radioresistance among human tumour
cells. In this regard, DNA repair-deficient cell lines have provided
a valuable insight into some ofthe mechanisms that are important
in determining the lethality of radiation-induced DNA damage.
The functional inactivation of the proteins involved in the
rejoining of DNA double-strand breaks (DSBs), e.g. those
encoded by the XRCC4, XRCC5 (Ku86) and XRCC7 (DNA-
PKCs), leads to the greatest increase in cellular radiosensitivity
(Giaccia et al, 1985; Taccioli et al, 1994; Kirchgessner et al, 1995;
Lees-Miller etal, 1995). Given the importance ofDSB rejoining to
the lethality of radiation-induced DNA damage, differences in
DSB-rejoining capacity might be expected to account for the vari-
ations in cellular radioresistance in human tumour cell lines.
Although there have been reports that DSB-rejoining rates corre-
late with radiosensitivity (e.g. Giaccia et al, 1992), therehave been
as many, if not more, studies that suggest that there is no correla-
tion between these parameters (reviewed in Olive et al, 1994).
Furthermore, there is no obvious relationship between the level
(XRCC5, XRCC6 and XRCC7) or activity (XRCC7) of DSB
repair proteins in human tumour cell lines exhibiting a range of
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radioresistance (Allalunis-Turner et al, 1995) that impacts on
patient radioresponsiveness (West et al, 1993).
It is becoming apparent that the 'DNA repair process' is consid-
erably more complex than simply the rejoining ofthe DNA strands.
Several cellular processes must be successfully integrated to facili-
tate the 'biologically effective' repair of radiation-induced DNA
damage. Forexample, the extreme radiosensitivity ofataxiatelang-
iectasia (AT) cells is due to a mutation in a P13 kinase-like gene
(Savitsky etal, 1995), which encodes aproteininvolved in intracel-
lular signalling. DSB rejoining can thus no longer be considered in
isolation as a determinant of radiosensitivity, but rather as a key
component of an integrated cellular response pathway. Given that
DSB repair capacity is a key, but not the sole, determinant of
radiosensitivity, it is probably not too surprising that there is a poor
correlation between DSB rejoining rates and radiosensitivity in
panels of cell lines ofdiffering radiosensitivity (reviewed in Olive
et al, 1994). In randomly selected human tumour cell lines, there
may be substantial differences in the cellular abilities to remove the
various DNA lesions or to invoke the various DNA damage
response pathways, e.g. cell cycle arrest, early-response genes or
the stress-activated protein kinase pathway. Although our knowl-
edge ofthese response pathways is limited, it seems likely that an
optimal co-ordination of these processes would be required to
produce a radioresistant phenotype. However, any defects within
the various response pathways or a defective temporal co-ordina-
tion ofthese processes - cell cycle arrest, DNA repair, suppression
of DNA synthesis, suppression of transcription and activation of
early-response genes - could lead to biologically inadequate repair
ofthe DNA damage and hence to a more radiosensitive phenotype.
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The high to intermediate ('clinically important') levels of radio-
resistance may thus reflect the degree to which the components of
the various DNA-damage response pathways are integrated with
each other and with other cellular processes.
In support of this hypothesis, the fidelity with which 'model'
(i.e. restriction endonuclease induced) DSBs are repaired does
indeed vary with respect to SF2 values in human tumour cell lines
(Powell and McMillan, 1991, 1994; Powell et al, 1992). In these
studies, the most radioresistant cell lines exhibit a higher fidelity
of DSB repair than their radiosensitive counterparts (Powell and
McMillan, 1991, 1994; Powell et al, 1992). However, as all of
these studies determined the fidelity of DNA repair that was
effected within the intact cellular environment, it is hard to estab-
lish whether the observed variations in DNA repair fidelity are a
reflection of inter-cell line differences in the 'processing' of the
DNA damage per se or are related to inter-cell line differences in
other factors that have been shown to influence the repair ofDNA
damage, e.g. higher order chromatin structures (Johnston and
Bryant, 1994). In an attempt to more definitively establish the
basis for the higher levels of DSB mis-rejoining in radiosensitive
tumour cells, we have used a cell-free plasmid reactivation assay
(North et al, 1990) to establish the fidelity of DSB repair that is
effected by nuclear protein extracts derived from radiosensitive
and radioresistant tumour cells.
MATERIALS AND METHODS
Cell lines
The origins and establishment of the human glioblastoma MOII,
M059K and M071 cell lines have previously been published
(Allalunis-Turner et al, 1992). All of these cell lines have
detectable levels of Ku7O, Ku86 and DNA-PKcs proteins
(Allalunis-Tumer et al, 1995).
Theorigins, establishment andclonal selection techniques used to
isolate the human cervical tumour cell lines have been previously
published (Britten et al, 1996a and b). Briefly, three primary human
cervical tumour cell lines were selected at random from approxi-
mately 200 in vitro cell cultures that were frozen down after only
three passages from date of establishment (Allalunis-Tumer et al,
1991). Afterbeing recovered from cryopreservation and maintained
for 2 weeks in exponential growth, single-cell colonies were isolated
by limiting dilution. From each cell line, randomly selected clones
were expanded and the resulting cell sublines maintained as mono-
layercultures in Dulbecco's Modified EagleMedium (DMEM)/F12
media, supplemented with 15% fetal calf serum (Gibco, Grand
Island, NY, USA) and antibiotics. After four further passages
(subcultured every 4-5 days to ensure exponential growth), the
radiosensitivity ofthese cloned cell lines was determined.
To facilitate inter-laboratory comparisons ofthe generated data,
we used Chinese hamster ovary (CHO)-AA8 cells as a reference
cell line. CHO-AA8 cells were maintained in monolayer culture in
McCoy's 5A medium (Hsu's modification; Gibco) supplemented
with 15% FCS and 1% penicillin-streptomycin. They were
passaged every 2-3 days to ensure exponential growth.
Radiation clonogenic cell survival assays
The radiosensitivity of the cell lines used in this study has been
previously established (Allalunis-Tumer et al, 1992, 1995; Britten et
al, 1996a and b). However, to ensure that the radiosensitivity ofthe
cells recovered from frozen storage had not altered and to facilitate a
better statistical comparison between radiosensitivity and DNA
repairfidelity, complete radiation survival curves (over the range of
0-10Gy) were constructed on the same batch of cell lines used to
preparethenuclearprotein extract. To ensurethattheradiation sensi-
tivity determined on this occasion was not erroneous, radiation
sensitivity was established a further two times in the subsequent 7
days. The radiosensitivity parameters presented in Table 1 represent
the pooled data from all three survival curve experiments. In no
instance did we find that the radiation sensitivity determined on the
daythattheprotein extract wasprepared variedfromeitherhistorical
data or from data observed in the subsequent assays. Theprocedure
followed for all of these experiments is outlined below. The day
before use, cells from exponentially growing stock cultures were
detached using 0.25% trypsin/I mm EDTA at 37°C and were placed
into two 75-cm2 flasks. On the day ofthe experiment, the media was
removed, the cell monolayers washed with sterile pre-warmed
(37°C) phosphate-buffered saline (PBS) and detached using 0.25%
trypsin/Il mm EDTA at 370C. The cell pellets were then washed
twice with warm PBS. One pellet was used to prepare the nuclear
protein extract (see below), while the other was resuspended in the
DMEM/F12 media, supplemented with 15% fetal calf serum
(Gibco) and antibiotics. Cells were seeded at densities of between
102 and 5 x 104 per 60 mm-tissue culture dish. Three replicate plates
were setupforeachofthefiveradiation doselevels. ThePetri dishes
were incubated for4 h at 370C (5% carbon dioxide/95% air) to allow
for cell attachment, then placed in aluminium irradiation chambers
and irradiated using a "OCo irradiator at a dose rate of 6 Gy min-.
After 15 days at 37°C (5% carbon dioxide/95% air), the colonies
were fixed in 70% ethanol and stained with 10% methylene blue,
and those colonies containing greater than 50 cells were counted.
Data handling and presentation
The experimental data were fitted to the linear-quadratic equation:
-Ln S = aD + 13D2
where S is equivalent to the surviving fraction at a given dose,
D, and a and 3 are constants. The data were fitted to a
linear-quadratic function using the non-linear regression program
of the PRIZM software package (Graphpad Software, San Diego,
CA, USA). SF2 values were calculated by substitution of the
derived constants into the linear quadratic equation.
Nuclear protein extracts
Nuclear protein was extracted (from the same batch of cells used
to determine radiosensitivity) in accordance with the method of
Olnes and Kurl (1994). Protein extracts were stored at-70°C (for
a maximum of 6 months) until required. The level of nuclear
protein obtained was determined using the Bio-Rad Protein Assay
(Bio-Rad Laboratories, Richmond, CA, USA) in accordance with
the manufacturer's instructions and using bovine serum albumin
(BSA) as aprotein standard. Before use in the plasmid reactivation
assay, the quality ofthe proteins was determined by separating the
protein by SDS/PAGE. The protein bands were visualized by
Coomassie blue staining.
DNA repair fidelity assay
A modified version of a cell-free plasmid reactivation system
(North et al, 1990) was used to assess DNA repair fidelity. This
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Table 1 Ampicillin-resistant bacterial clones generated aftertransfection of
DH5a bacteria with EcoRl-digested pUC18 molecules after exposure to
various amounts of HT137/1 nuclear protein extract
Nuclear protein Total no. No. of white LacZa-deficient
(gig) of coloniesa coloniesa cells (%)
0.1 102 2 1.9
0.5 110 2 1.8
1.0 132 3 2.3
2.5 70 1 1.4
5.0 0 0 0
10 0 0 0
25 0 0 0
aNumber of colonies above 'background' level of plasmid rejoining, i.e. in the
absence of nuclear protein.
Table 2 Radiation survival curve parameters of the cell lines studied
(standard error in parentheses)
Cell line a (Gy-') B (Gy-2) SF2 Do. (Gy)
Moil 0.907 (0.186) 0.111 (0.058) 0.10 2.04
M071 0.932 (0.167) 0.029 (0.043) 0.14 2.31
HT212/7 0.433 (0.031) 0.005 (0.004) 0.41 5.03
HT212/10 0.323 (0.014) < 0.0001 0.52 7.11
HT137/1 0.240 (0.033) 0.021 (0.004) 0.56 6.21
HT212/4 0.229 (0.042) 0.025 (0.005) 0.57 6.05
M059K 0.129 (0.093) 0.059 (0.011) 0.61 5.25
CHO-AA8 0.154 (0.022) 0.032 (0.002) 0.64 6.41
HT180/7 0.050 (0.032) 0.051 (0.007) 0.74 6.25
technique uses double-stranded pUC18 DNAcontaining the lacZa
complementation gene and the ampicillin-resistance gene (ampr).
The DNA was isolated from HB1I1 bacteria containing the
pUC18 plasmid using a plasmid Maxi Kit (Qiagen, Chatsworth,
CA, USA). A single DSB was then introduced within the lacZa
gene by the EcoRI restriction endonuclease (Pharmacia,
Piscataway, NJ, USA). After heat inactivation of the EcoRI (20
min at 65°C), the plasmid was ethanol precipitated and the cutting
efficiency checked by Southern analysis (see below). In the initial
stages of this study, the amount of nuclear protein extract that
yielded the greatest number of colonies was ascertained. The
optimum protein level was found to be 1 jg (Table 1); at higher
protein levels, there was a noticeable drop in the number ofbacte-
rial transformants and anoticeable degradation oftheplasmid after
electrophoretic separation. This level of nuclear protein was
approximately 30-fold less than that of the cytoplasmic extracts
used in the earlier studies using this assay (North et al, 1990),
which presumably reflects the greater concentration of DNA-
processing enzymes in the nuclear vs cytoplasmic protein extracts.
The experimental conditions used to derive the data presented in
this paper were as described below. Two micrograms oflinearized
plasmid DNA and 1 jg of nuclear protein extract were mixed in
50 jl containing 50 mM Tris-HCl (pH 7.6), 10 mm magnesium
chloride, 1 mm ATP, 1 mM DTT, 50gM dNTPs and 5% (w/v) poly-
ethylene glycol-8000 and were incubated at 18°C for 24 h. The
plasmid DNA was then isolated by spinning down the reaction
mixture through Ultrafree-Probind Filter column (Millipore
Corporation, Bedford, MA, USA). Forquality control purposes, an
aliquot was removed and treated with T4-ligase (Gibco) before
being further processed.
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Figure 1 The relationship between plasmid rejoining levels and SF2 values
(A) or 0o1 values (B) in early-passage human cervical (0, HT137/1; O,
HT212/4; *, HT212/7; 0, HT212/10; *, HT18017) and glioma (MOll, A;
M059K, V; and M071, C) tumour cells and in CHO-AA8 (A) cells. Rejoining
capacity was assayed by at least three separate experiments
The recovered plasmid was diluted fivefold with TE buffer
(pH 7.6) and then transfected into the E. coli DH5a strain using
the Gibco-BRLprotocol forDH5a bacteria. The transformed cells
were then mixed with 3 ml of LM medium/0.7% agar containing
67 jig ml-l ampicillin, 266 jig ml-1 X-gal (5-bromo-4-chloro-3-
indolyl-13-D-galactopyranoside) and 266jig ml' of IPTG (an
inducer of lacZa gene function) and were then poured onto pre-
made LM plates containing 100 jg ml' ampicillin. An aliquot of
cells was alsoplated out on LM plates that contained no ampicillin
to determine bacterial cell viability/plating efficiency. After
ovemight incubation at 37°C, the colonies were visualized, and
those greater than 1 mm in diameter were counted. Correct
rejoining of the DSBs produced DNA that yielded dark-blue
colonies. Mis-rejoining of the DSBs resulted in a mutated lacZa
sequence that produced colourless colonies. As the functional
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Table 3 Ampicillin-resistant bacterial clones generated after transfection of DH5a bacteria with EcoRI-digested pUC18
molecules after exposure to T4 ligase or to varous nuclear protein extracts
Treatment Total colonies White colonies Misrepair Total colonies
produceda produceda frequency producedb
EcoRl only 43.44 ± 13.22 0.055 ± 0.055 0 46.82 ± 21.07
EcoRl-T4 ligase 4950 ± 45.92 0.33± 0.31 0 5125 ± 67.23
EcoRl e nuclear protein - T4 ligase 5744 ± 67.12 0.19 ± 0.08 0 5463 ± 79.19
Mo01 181.5 ± 10.81 14.83 ± 0.75 8.29 ± 0.54 206.60 ± 11.03
M071 241.33 ± 45.21 14.66 ± 0.56 5.16 ± 0.17 315.60 ± 19.84
HT137/1 74.5 ± 5.60 2.33 ± 0.21 3.19 ± 0.29 99.65 ± 9.56
HT212/7 239.33 ± 35.75 10.5 ± 1.61 4.38 ± 0.17 246.20 ± 38.25
HT212/10 200.67 ± 14.09 8.0 ± 0.89 4.05 ± 0.49 218.50 ± 12.14
HT212/4 132.17 ± 19.24 3.83± 0.74 2.83± 0.24 149.40± 21.81
M059K 413.25 ± 50.13 10.67 ± 1.57 2.53± 0.25 391.80± 42.27
CHO-AA8 126.66 ± 21.60 4.33 ± 1.85 3.18 ± 0.85 164.20 ± 27.77
HT180/7 83.33 ± 6.58 1.44 ± 0.24 1.77 ± 0.27 109.50 ± 8.53
aNumber of ampicillin-resistant bacterial colonies produced per 104 bacterial cells plated. bNumber of ampicillin-resistant
bacterial colonies produced normalized to bactenal cell viability. Values represent the mean values ± s.e.m. of data that have
been corrected for 'background' plasmid rejoining by subtraction of internal control data.
(a-complementation of 3-galactosidase) inactivation ofthe lacZa
gene had no direct effect on cellular viability, the full spectrum of
DSB mis-rejoining events was probably conserved. The 'mutant'
colonies were restreaked onto fresh selection media to verify the
mutation in the lacZa gene.
Comparative studies of the DSB rejoining capacity/fidelity in
the CHO-AA8 and human tumour cell lines were performed
simultaneously using the same batch of competent cells, reagents
and EcoRI-digested plasmid DNA. A minimum of three experi-
ments were performed with each nuclear protein extract, the
results presented in this paperrepresent the pooled datafrom these
experiments. To eliminate the confounding effects ofthe presence
of uncut plasmid and of rejoining events within the bacteria, the
level ofDSB rejoining and/ormis-rejoining thatoccurred irrespec-
tive of exposure to nuclear proteins was determined for each
experiment and subtracted from the experimental data before
further analysis.
Southern analysis
A0.5-,ug aliquot ofplasmid was subjected to gel electrophoresis in
1% agarose gel, transferred to Hybond-N+ nylon membranes
(Amersham, Arlington Heights, IL, USA) by capillary blotting
and baked at 800C for 2 h. After prehybridization of the
membranes for 4 h at 450C in Hybrisol I (Oncor, Gaithersburg,
MD, USA), the membrane was hybridized with 32P-labelled
pUC18 probe for 18 h at 45°C. Unbound probe was removed by
washing membranes three times in 2 x SSC/l% sodium dodecyl
sulphate (SDS) at room temperature and twice in 0.1 x SSC/0.1%
SDS at 60°C. The membranes were then enclosed in plastic wrap
and placed in a phosphor-imager cassette for 1 h, after which they
were scanned with a GS-250 Molecular Imager (BioRad,
Mississauga, Ontario, Canada).
Mapping of mis-rejoined pUC18 molecules
Plasmid DNA was isolated from nine randomly selected 'white'
and ten 'blue' clones generated after exposure to the nuclear
protein extract of the HT137/1 cell line. The nature of the muta-
tions in the LacZa gene after incubation with nuclear protein
extracts was characterized by restriction endonuclease digest and
by PCR amplification. The plasmid DNA was digested with the
following restriction endonucleases (either singularly or in combi-
nation): EcoRI, NdeI, PvuI, PvuII, AatI or PstI (Pharmacia,
Piscataway, NJ, USA).
The multiple-cloning region was amplified using the M13/pUC
sequencing primers (Gibco) listed below: forward, 5'-CCCAG
TCACG ACGTT GTAAA ACG-3' (primer F); reverse, 5'-
AGCGG ATAAC AAl7TT CACAC AGG-3' (primer R). These
primers give a 136-bp product (corresponding to nucleotides
364-500) when used on untreated pUC18 DNA.
In certain instances, the region of the pUC18 plasmid corre-
sponding to nucleotides 150-777 was also amplifiedusing another
set ofprimers: forward, 5'-CGGCA TCAGA GCAGA TTGTA-3'
(primer 2F); reverse, 5'-TGGAT AACCG TATTA CCGCC-3'
(primer 2R). This second set of primers give a 628-bp product
when used on untreated pUC18 DNA.
PCR was performed using a GeneAmp PCR system 9600
(Perkin Elmer) and the following conditions: 95°C for 2 min; 35
cycles of 95°C for 15 s, 60°C for 30 s, 72°C for 15 s; 72°C for
7 min. Limiting dilution analysis revealed that a PCR product was
detectable when the target sequence was present in a concentration
as low as 10 fg.
RESULTS
The human tumour cell lines studied exhibited a wide range of
radiosensitivities. Comparative analysis of SF2 values revealed a
7.4-fold variation in clinically relevant radiosensitivity (0.10> SF2
< 0.74). When assessed at the 10% survival level(Do.1) there was
a 3.5-fold variation in the radiosensitivity ofthese cell lines, with a
range of Do.1 values from 2.0 to 7.1 Gy. The radiation survival
curve parameters of the CHO-AA8 and the eight human tumour
cell lines are listed in Table 2.
After verification of the quality (i.e. no degradation) of the
nuclear protein extracts by SDS/PAGE analysis, the ability of 1 jg
ofthe nuclear protein extracts to rejoin the EcoRI-digested pUC18
(EDP) plasmid was assessed. EDP plasmid that was exposed to
nuclear protein extracts yielded transformation frequencies within
the range of74-413 colonies 10- competent cells (Table 2). There
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Figure 2 The relationship between DSB mis-rejoining levels and SF2 values
(A) orDoA values (B) in early-passage human cervical (0, HT137/1; E,
HT212/4;*, HT212/7; 0, HT212/10; *, HT180/7) and glioma (MOll, A;
M059K, V; and M071, C) tumour cells and in CHO-AA8 (A) cells. Mis-
rejoining capacity was assayed by at least three separate expenments.-,
Best-fit by linear regression analysis; - - -, 95% confidence intervals
was no obvious correlation between the radiosensitivity of the
tumour cell line and the capacity of the nuclear protein extract to
rejoin the EDP plasmid (as determined by transformation
frequency), neither when expressed relative to bacterial cells
plated [r2 = 0.05, P = 0.56 (SF2) and r 2 = 0.09, P = 0.43 (Do1),
d.f. = 6] (Figure 1) nor when corrected for bacterial cell viability
[r2 = 0.11, P = 0.42 (SF2) and r2 = 0.16, P = 0.34 (Do,), d.f. = 6].
The range oftransformation frequencies after exposure ofthe EDP
plasmid to the nuclear protein extract was between 4% and 18% of
that accrued when the EDP plasmid was treated by T4 ligase
(approximately 5000 colonies 10- competent cells) but was signif-
icantly higher than that observed when EDP that was not exposed
to either nuclear protein or T4 ligase was used to transform the
bacteria (32-45 colonies 10- competent cells) (Table 3).
T4 ligase treatment of EDP plasmid that had been previously
exposed to nuclear protein extracts yielded transformation
frequencies similar to that obtained after T4 ligase treatment alone
(Table 3). It would thus appear that the nuclear protein extracts
were capable of rejoining about 10% of the re-ligatable plasmid
molecules and that there was not a significant degradation of the
EDP plasmid by the nuclear protein extract. Moreover, as the
frequency of DSB mis-rejoining after this treatment was not
significantly different to that observed when T4 ligase was used
alone (and it did not resemble that observed after nuclear protein
treatment alone), it would appear that the nuclear protein-mediated
increase in DSB mis-rejoining frequency was not attributable to a
random degradation of the plasmid, but rather arose as a conse-
quence of the nuclear protein-mediated rejoining of the DSBs.
There was a 4.7-fold range in the fidelity of DSB rejoining (as
determined by the proportion of colonies with a non-functional
lacZa gene, i.e. white colonies) achieved by nuclear protein
extracts (Table 3). The CHO-AA8 cell line exhibited a low
frequency of DSB mis-rejoining. The human cervical (HT212/4)
tumour cell line that exhibited similar levels of radioresistance as
the CHO-AA8 cells exhibited a similar DSB mis-rejoining
frequency. The more radiosensitive human tumour cells exhibited
higher frequencies of DSB mis-rejoining (Figure 2), while the
more radioresistant HT180/7 cell line exhibited a lower DSB
mis-rejoining frequency than CHO-AA8 cells. Linear regression
analysis indicates that there was a significant (r2 = 0.84, P = 0.001,
df = 6) correlation between SF2 values and the fidelity of DSB
rejoining (Figure 2) and, to a lesser extent (r2 = 0.62, P = 0.02,
d.f. = 6), between Do1 values and DSB rejoining fidelity (Figure 2).
To assess whether the inactivation of the lacZa gene was attrib-
utable to deletional events, as previously suggested by Thacker et
al (1992), we performed restriction endonuclease mapping, as well
as PCR amplification ofthe multiple-cloning region, ofthe pUC18
plasmid recovered from a number of blue and white colonies
generated after exposure to the nuclear protein extract of the
HT137/1 cell line. The region of the pUC18 plasmid containing
the relevant restriction sites and PCR primer recognition
sequences is depicted in Figure 3.
The PstI and EcoRI sites were absent from the DNA obtained
from four white colonies. No PCR product was generated when the
first set of PCR primers was used to amplify the DNA from those
plasmids that did not contain the PstI and EcoRI recognition sites.
These data suggest that at least one of the primer recognition
sequences has either been deleted or altered. In one ofthese clones
(W8), we have confirmed that the recognition site for primer F was
indeed deleted as this clone did not contain any of the recognition
sites between nucleotide 183 (NdeI) and nucleotide 450 (EcoRI)
(Table 4, Figure 3). To get a more accurate determination of the
size ofthe deletions, a second set ofPCR primers (2F and 2R) was
selected whose recognition sequences corresponded to regions 5'
to the NdeI site and 3' to the PvuII (nt. 628) recognition sequences.
As expected, a single PCR product of 628 bp was generated in the
blue clones tested. At this stage, plasmid DNA was only available
from three of the nine white colonies: WI, W5 and W8. A single
PCR product was generated in all three clones, however this
product was approximately 628 bp, 330 bp and 180 bp in size from
the WI, W5 and W8 clones respectively. In the case of the Wl
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Figure 3 (A) Depiction of the region of the pUC18 plasmid containing the relevant restrction sites and PCR prmer recognition sequences used to characterize
the mis-rejoined molecules. (B) Depiction of the size and location of deleted regions of the plasmid recovered from LacZa-deficient bacterial clones. Solid areas
represent those areas of the plasmid that are known to be missing, while the shaded areas represent those regions of the plasmid that are potentially delected
or altered
Table 4 Restriction enzyme mapping and PCR amplification of lacZa-deficient colonies
Restriction enzyme site present
Aatll Ndel Pvul Pvull Pstl EcoRI Pvull PCR1 PCR2
Clone (2617) (183) (276) (306) (410) (450) (628) product product
Wi + + + + + + + + -628 bp
W2 + + + + - - + - ND
W3 + + + + + + + + ND
W4 + + + + - - + - ND
W5 + + + + - - + - -330 bp
W6 + + + + + + + + ND
W7 + + + + + + + + ND
W8 + - - - - - + - 180 bp
W9 + + + + + + + + ND
PCR1 denotes those expenments performed using PCR primers F and R; + signifies that a 136-bp
product was formed. PCR2 denotes those experiments performed using PCR primers 2F and 2R;
when the analysis was performed, the approximate size of the fragment is listed. ND signifies that
PCR analysis was not performed.
clone, the inactivation ofthe lacZa gene would appear to be attrib-
utable to the loss of a few nucleotides from the original EcoRI
restriction site. In the case ofthe W5 clone, it would appear that a
deletion of approximately 300 bp in size accounted for the inacti-
vation of the lacZa gene, while in the W8 clone a -448-bp dele-
tion led to the inactivation ofthe lacZa gene. In the two instances
for which we have sufficient data from the restriction digest and
PCR analysis to accurately determine the size and location of the
deletional events, it appears that, in the W8 clone, the deletions
occurred preferentially 5' to the original EcoRI cut, whereas, in the
W5 clone, approximately the same amount of material was lost 3'
as was lost 5' to the EcoRI site (Figure 3B).
DISCUSSION
In this study, we found that the fidelity of DSB rejoining (as
detectedby acell-free plasmidreactivation assay) was significantly
(P <0.001, r2 = 0.84, d.f. = 6) correlated with the clinically relevant
radiosensitivity, i.e. SF2, of the eight human tumour cell lines
studied (Figure 2). It would thus appear that this assay is sensitive
to differences in the nuclear protein composition of radiosensitive
and radioresistant cells that reflect the clinically relevant radio-
sensitivity of these cell lines. These data confirm and extend the
findings of previous investigators who showed that radiosensitive
tumour cells rejoin restriction endonuclease-induced DSBs with a
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lower fidelity than their radioresistant counterparts (Bryant and
Liu, 1994; Powell and McMillan, 1994). The fact that our cell-free
assay yielded similar results to these previous studies that used
intracellular plasmid reactivation assays suggests that those differ-
ences in DSB mis-rejoining frequencies in radiosensitive and
radioresistant cell lines (Powell and McMillan, 1994) may be due
to inherent differences in nuclear protein composition and are not
directly attributable to differences in proliferation rates between
cell lines.
The biochemical basis for the differential level of DSB mis-
rejoining in the nuclear protein extracts from radiosensitive and
radioresistant tumour cells is presently unknown. It appears that
cell-free plasmid reactivation assays are sensitive to DSB rejoining
processes that are far more complex than simple ligation. Previous
characterization ofthe cell-free plasmid reactivation assay used in
this study suggests that multiple proteins are required in addition
to the known ligases to rejoin restriction endonuclease-induced
DSBs (Fairman et al, 1992). For example, fractionation of the
protein extracts revealed that the level of plasmid rejoining is
influenced by proteins within a specific fraction that was desig-
nated 'rejoining enhancing proteins' (Fairman et al, 1992). Recent
data suggest that in vitro DSB rejoining assays that use restriction
endonuclease-induced DSBs may detect only a subset ofthe path-
ways that are used in vivo to rejoin radiation-induced DSBs
(Perrault et al, 1997). Ithas been suggested thatrestriction endonu-
clease-generated DSBs act as substrates for proteins that are
involved in the (abnormal) conversion ofDSBs into chromosomal
aberrations (Bryant and Liu, 1994). This conclusion is supported
by several studies on AT and hamster irs cells that exhibit no
apparent defect in DSB rejoining; yet they are extremely sensitive
to radiation (Taylor et al, 1975) and also exhibit high DSB mis-
rejoining activities (Cox et al, 1984; Thacker and Ganesh, 1990;
Ganesh et al, 1993; Powell et al, 1993; Luo et al, 1996) and
enhanced levels of chromatid-type aberrations (Liu and Bryant
1993, Bryant and Liu, 1994) in cell-free and intracellular plasmid
reactivation assays. The strong correlation between the level of
radiation-induced chromosomal aberrations and the radiosensi-
tivity oftumour (Lambin et al, 1994; Sasai et al, 1994) and human
fibroblast (Russell et al, 1995) cells would certainly explain the
correlation between the fidelity ofDSB rejoining and SF2 values if
the plasmid reactivation assay does detect the activity of enzymes
involved in the processing ofDSBs into chromosomal aberrations.
The identity of the enzymes that might be responsible for the
differential level of DSB mis-rejoining in radiosensitive and
radioresistant tumour cells remains largely speculative, however
our characterization of the nuclear protein extract-induced muta-
tions within the lacZa gene may have given some insight into their
identity. Restriction endonuclease mapping and PCR amplification
analysis ofthe mutant clones generated in ourexperiments suggest
that the inactivation ofthe lacZa gene was attributable (45% ofthe
time) to deletions of at least 40 bases and as much as 440 base
pairs. These data are consistent with previous studies in which the
majority of the mutations that lead to a defective lacZa gene
(when cellular protein extracts from AT cells were used) was
primarily deletions and insertions (Thacker et al, 1992). In those
studies, these mutations were shown to arise because of illegiti-
mate recombination, i.e. the DNA recombines at short sequence
repeats that are frequently far apart (Thacker et al, 1992).
In conclusion, we have demonstrated that nuclear protein
extracts from overtly DSB repair-proficient radiosensitive tumour
cells are less capable of correctly rejoining EcoRI-induced DSBs
than similar extracts from radioresistant tumour cells. Our data
suggest that the higher level of DSB mis-rejoining in radiosensi-
tive tumour cells is not a consequence of non-specific endo-
nuclease activity, but rather due to an increase in non-conservative
DSB rejoining activity, resulting in losses of between 40 and 440
base pairs of DNA. These data raise the possibility that the
radiosensitivity of DSB repair-proficient human tumour cell lines
may be partly determined by the predisposition of these cell lines
to activate non-conservative DSB rejoining pathways.
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